DEVELOPMENT OF A RISK STRATIFICATION SCORING SYSTEM FOR EARLY NUTRITIONAL INTERVENTION IN PATIENTS WITH THORACIC ESOPHAGEAL CANCER AT THONG NHAT HOSPITAL

Do Nhan Nguyen1,
1 Thong Nhat Hospital

Main Article Content

Abstract

Background: Nutrition is a key factor in multimodal treatment of esophageal cancer. Nutritional assessment, early intervention remain challenging, with limited data available in the elderly population. Objectives: To evaluate malnutrition and to develop a risk stratification scoring system for malnutrition in patients with thoracic esophageal cancer. Materials and methods: A descriptive cross-sectional study was conducted on 65 patients with thoracic esophageal cancer treated at Thong Nhat Hospital from 06/2020 to 06/2025. Results: The prevalence of malnutrition risk among patients aged >70 years was 46.1%; BMI <18.5 kg/m² in 38.5%; serum albumin <35 g/L in 41.5%; weight loss >5% within 6 months in 56.9%. The proportion of patients at nutritional risk (NRS-2002 > 3) was 81.5%; malnutrition (GLIM) was 73.8%. The proposed risk stratification/score: low (0-2), moderate (3-5), high (≥6). The ROC curve (cut-off > 3) showed a sensitivity of 89.5% and a specificity of 70.0% in identifying malnutrition risk. Conclusion: Malnutrition was high in the study group. The proposed malnutrition risk score demonstrates good sensitivity and specificity for screening and holds potential for early nutritional intervention. 

Article Details

References

1. Moghaddam OM, Emam MH, et al. Relation between nutritional status on clinical outcomes of critically ill patients: emphasizing nutritional screening tools in a prospective cohort investigation. BMC Nutr. 2024. 10:69, doi: 10.1186/s40795-024-00869-3.
2. Jensen GL, Cederholm T, Correia MITD, Gonzalez MC, et al. The GLIM consensus approach to diagnosis of malnutrition: A 5-year update. Clin Nutr. 2025. 49(3), 414-427, doi: 10.1016/j.clnu.2025.03.018.
3. Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N et al. ESPEN Practical Guideline: Clinical Nutrition in Cancer. Clin Nutr. 2021. 40(11), 2898-2913, doi: 10.1016/j.clnu.2021.02.005.
4. Shinsuke Suzuki, Yukie Taguchi et al. Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab. J. Clin. Med. 2024. 13(9), 2456, https://doi.org/10.3390/jcm13092456.
5. Li Y, Chong F, Huo Z, Li N, Liu J, Xu H, et al. GLIM-defined malnutrition and overall survival in cancer patients: a meta-analysis. J Parenter Enteral Nutr. 2023. 47(2), 207-219, doi:10.1002/jpen.2463.
6. Kevin Ly, Dorothy Wakefield, et al. The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD. Journal of Multimorbidity and Comorbidity. 2025. 15, https://doi.org/10.1177/26335565251315876.
7. Jensen GL, Cederholm T, Correia MITD, et al. GLIM criteria for malnutrition diagnosis. JPEN. 2021. 45(5), 1155-1160, DOI: 10.1002/jpen.1440.
8. Zeng X, Xu X, Li Q, Huang J, Wang Y, Liu D, et al. Development and validation of a prognostic nomogram for overall survival in patients with esophageal squamous cell carcinoma: a SEERbased study. Front Immunol. 2025. 16,1524439, doi:10.3389/fimmu.2025.1524439.